Display Settings:   Send to:  Choose Destination  Intensive
versus conventional glucose control in critically ill patients.
Collaborators (203)  Finfer S, Blair D, Bellomo R, McArthur C,
Mitchell I, Myburgh J, Norton R, Potter J, Chittock D, Dhingra
V, Foster D, Cook D, Dodek P, Hébert P, Henderson W, Heyland D,
McDonald E, Ronco J, Schweitzer I, Peto R, Sandercock P, Sprung
C, Young JD, Su S, Heritier S, Li Q, Bompoint S, Billot L,
Crampton L, Darcy F, Jayne K, Kumarasinghe V, Little L, McEvoy
S, MacMahon S, Pandey S, Ryan S, Shukla R, Vijayan B, Atherton
S, Bell J, Hadfield L, Hourigan C, McArthur C, Newby L, Simmonds
C, Buhr H, Eccleston M, McGuinness S, Parke R, Bellomo R, Bates
S, Goldsmith D, Mercer I, O'Sullivan K, Gazzard R, Hill D,
Tauschke C, Ghelani D, Nand K, Reece G, Sara T, Elliott S,
Ernest D, Hamilton A, Ashley R, Bailey A, Crowfoot E, Gissane J,
Mitchell I, Ranse J, Whiting J, Douglas K, Milliss D, Tan J,
Wong H, Blythe D, Palermo A, Hardie M, Harrigan P, McFadyen B,
Micallef S, Parr M, Boas